Cibc Private Wealth Group, LLC Exelixis, Inc. Transaction History

Cibc Private Wealth Group, LLC

  • $51.4 Billion
  • Q2 2024

A detailed history of Cibc Private Wealth Group, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 694 shares of EXEL stock, worth $18,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares
694
Previous 694 -0.0%
Holding current value
$18,349
Previous $16,000 6.25%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$20.17 - $23.93 $13,997 - $16,607
694 New
694 $16,000
Q2 2022

Aug 03, 2022
SELL
$17.44 - $23.16 $44,995 - $59,752
-2,580 Reduced 18.35%
11,482 $239,000
Q1 2022

May 16, 2022
BUY
$17.03 - $22.67 $239,475 - $318,785
14,062 New
14,062 $319,000
Q4 2021

Feb 08, 2022
SELL
$15.84 - $21.88 $198,776 - $274,572
-12,549 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$16.3 - $21.14 $63,423 - $82,255
-3,891 Reduced 23.67%
12,549 $266,000
Q2 2021

Aug 16, 2021
SELL
$17.95 - $25.56 $25,830 - $36,780
-1,439 Reduced 8.05%
16,440 $299,000
Q1 2021

May 12, 2021
SELL
$20.53 - $25.22 $26,175 - $32,155
-1,275 Reduced 6.66%
17,879 $404,000
Q3 2020

Nov 03, 2020
BUY
$20.67 - $26.94 $395,913 - $516,008
19,154 New
19,154 $469,000
Q3 2020

Oct 29, 2020
SELL
$20.67 - $26.94 $404,987 - $527,835
-19,593 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$16.46 - $27.42 $823 - $1,371
50 Added 0.26%
19,593 $465,000
Q1 2020

May 15, 2020
BUY
$14.46 - $21.8 $282,591 - $426,037
19,543 New
19,543 $336,000
Q4 2019

Jan 30, 2020
SELL
$15.15 - $18.89 $312,559 - $389,719
-20,631 Closed
0 $0
Q3 2019

Oct 16, 2019
BUY
$17.68 - $22.65 $39,850 - $51,053
2,254 Added 12.27%
20,631 $365,000
Q2 2019

Jul 31, 2019
BUY
$18.93 - $24.75 $74,186 - $96,995
3,919 Added 27.11%
18,377 $393,000
Q1 2019

May 10, 2019
BUY
$19.6 - $24.76 $62,837 - $79,380
3,206 Added 28.49%
14,458 $344,000
Q4 2018

Feb 05, 2019
BUY
$13.65 - $21.8 $153,589 - $245,293
11,252 New
11,252 $221,000
Q3 2018

Nov 14, 2018
SELL
$15.87 - $22.4 $33,882 - $47,824
-2,135 Closed
0 $0
Q2 2018

Aug 02, 2018
SELL
$18.56 - $22.45 $649 - $785
-35 Reduced 1.61%
2,135 $46,000
Q1 2018

May 17, 2018
SELL
$22.15 - $31.89 $5,869 - $8,450
-265 Reduced 10.88%
2,170 $48,000
Q4 2017

Feb 12, 2018
BUY
$24.23 - $30.93 $59,000 - $75,314
2,435
2,435 $74,000

Others Institutions Holding EXEL

# of Institutions
460
Shares Held
240M
Call Options Held
2.04M
Put Options Held
1.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $8.51B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email